3
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Pathophysiology of Increased Urinary N-Acetyl-β-D-Glucosaminidase Activity in Human Hypertension: Effect of Cilazapril Therapy

&
Pages 767-777 | Published online: 23 May 2017

  • Mansell MA, Jones NF, Ziroyannis RN et al. Detection of renal artery stenosis by measuring urinary N-acetyl-beta-D-glucosaminldase. Br. Med. J. 1978; 1:414–415.
  • Mansell MA, Jones NF, Ziroyannis RN et al. N-acetyl-B-D-glucosaminidase: a new approach to the screening of hypertensive patients for renal disease. Lancet 1970; 2:803–805.
  • Maruhn D. Evaluation of urinary enzyme patterns in patients with kidney disease and primary benign hypertension. Curr. Probl. Clin. Biochem. 1979; 9:135–149.
  • Simon G, Morioka S, Snyder DK. Increased serum and urinary N-acetyl-B-D-glucosaminidase activity in human hypertension: early indicator of renal dysfunction. Clin. Exper. Hyper. 1984; A6:879–896.
  • Simon G, Altman S. Increased serum N-acetyl-6-D-glucosamlnldase activity in human hypertension. Clin. Exper. Hyper. 1982; A4:355–365.
  • Simon G, Altman S. Increased serum glycosidase activity in human hypertension. Clin. Exper. Hyper. 1984; A6:2219–2233.
  • Raab WP. Diagnostic value of urinary enzyme determinations. Clin. Chem. 1972; 18:5–25.
  • Dingle JT. The extracellular secretion of lysosomal enzymes. In: Lysosomes in Biology and pathology. Dingle JT, Fell HB, eds. Amsterdam, North Holland, 1973.
  • Roos JC, Kirchner KA, Abernethy JD et al. Differential effect of salt loading on sodium and lithium excretion in Dahl salt-resistant and -sensitive rats. Hypertension 1984; 6:420–424.
  • Weder, AB. Red cell lithium-sodium counter-transport and renal clearance in hypertension. New Eng. J. Med. 1986; 314:198–201.
  • Langford HG, Montani M, Roos JC et al. Proximal renal tubular reabsorption is increased in essential hypertension. Clin. Res. 1986; 34: 666a.
  • Alderman MH, Melcher L, Drayer DE et al. Increased excretion of urinary N-acetyl-g-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. New Eng. J. Med. 1983; 309:1213–1217.
  • Thomsen K, Schou M, Steiness I et al. Lithium as an indicator of proximal sodium reabsorption. Pfluegers Arch. 1969; 308:180–184.
  • Thomsen K, Holstein-Rathlou NH, Leyssac PP. Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time and micropuncture. Am. J. Physiol. 1981; 241 :F348–F355.
  • Fredriksson A. Renal handling of B2-microglobulin in experimental renal disease. Scand. J. Clin. Lab Invest. 1975; 35:591–600.
  • Sherman RL, Drayer DE, Leyland-Jones R et al. N-acetyl-B-glucosaninidase and B2-microbulin: theih urinary excretion in patients with renal parenchymal disease. Arch. Int. Med. 1983; 143 : 1183–1185.
  • Bruun NE, Ibsen H, Skott P, et al. Redistribution of renal tubular sodium resorption during long-term treatment with nifedipine in patients with essential hypertension. J. Hypertension 1986; suppl. 6:S177–3179.
  • Bauer JH, Reams GP. Renal effects of angiotensin converting enzyme inhibitors. Am. J. Med. 1986; Suppl 4C : 19–27.
  • Romero CJ, Raij L, Granger JP et al. Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 1987, 10:140–151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.